EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization

Juan F Hernandez-Franco iD, Ganesh Yadagiri iD, Veerupaxagouda Patil iD, Dina Bugybayeva, Sara Dolatyabi iD, Ekachai Dumkliang iD, Mithilesh Singh, Raksha Suresh, Fatema Akter, Jennifer Schrock, Gourapura J Renukaradhya, Harm HogenEsch iD

Vaccines · 07.11.2023 · 11 (11) · 1699

DOI: 10.3390/vaccines11111699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 07.11.2023. Verfasst von Juan F Hernandez-Franco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture, USDA Hatch formula funds, United States Department of Agriculture, National Institute of Food and Agriculture (USDA–NIFA) Agriculture and Food Research Initiative (AFRI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of cross-protective vaccines against the zoonotic swine influenza A virus (swIAV), a potential pandemic-causing agent, continues to be an urgent global health concern. Commercially available vaccines provide suboptimal cross-protection against circulating subtypes of swIAV, which can lead to worldwide economic losses and poor zoonosis deterrence. The limited efficacy of current swIAV vaccines demands innovative strategies for the development of next-generation vaccines. Considering that intramuscular injection is the standard route of vaccine administration in both human and veterinary medicine, the exploration of alternative strategies, such as intradermal vaccination, presents a promising avenue for vaccinology. This investigation demonstrates the first evaluation of a direct comparison between a commercially available multivalent swIAV vaccine and monovalent whole inactivated H1N2 swine influenza vaccine, delivered by intradermal, intranasal, and intramuscular routes. The monovalent vaccines were adjuvanted with NanoST, a cationic phytoglycogen-based nanoparticle that is combined with the STING agonist ADU-S100. Upon heterologous challenge, intradermal vaccination generated a stronger cross-reactive nasal and serum antibody response in pigs compared with intranasal and intramuscular vaccination. Antibodies induced by intradermal immunization also had higher avidity compared with the other routes of vaccination. Bone marrow from intradermally and intramuscularly immunized pigs had both IgG and IgA virus-specific antibody-secreting cells. These studies reveal that NanoST is a promising adjuvant system for the intradermal administration of STING-targeted influenza vaccines.

Schlagwörter

Stichwörter der Autor:innen

STINGadjuvantsinfluenzaintradermalnanoparticlesswinevaccines

Autor:innen und Institutionen

  • Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA.
  • Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, Wooster, OH 44691, USA.
  • Drug Delivery System Excellence Center (DDSEC), Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90110, Thailand.
  • Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN 47907, USA.

ORCID-Profile: Juan F Hernandez-Franco, Ganesh Yadagiri, Veerupaxagouda Patil, Sara Dolatyabi, Ekachai Dumkliang, Harm HogenEsch

Förderung

  • United States Department of Agriculture
  • USDA Hatch formula funds
  • United States Department of Agriculture, National Institute of Food and Agriculture (USDA–NIFA) Agriculture and Food Research Initiative (AFRI)
  • USDA–NIFA Hatch formula funds

Zitieren

APA

Hernandez-Franco, J. F., Yadagiri, G., Patil, V., Bugybayeva, D., Dolatyabi, S., Dumkliang, E., Singh, M., Suresh, R., Akter, F., Schrock, J., Renukaradhya, G. J., & HogenEsch, H. (2023). Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization. Vaccines, 11(11), 1699. https://doi.org/10.3390/vaccines11111699

Vancouver

Hernandez-Franco JF, Yadagiri G, Patil V, Bugybayeva D, Dolatyabi S, Dumkliang E, et al. Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization. Vaccines. 2023;11(11):1699. doi:10.3390/vaccines11111699

BibTeX
@article{HernandezFranco2023,
  author = {Hernandez-Franco, Juan F and Yadagiri, Ganesh and Patil, Veerupaxagouda and Bugybayeva, Dina and Dolatyabi, Sara and Dumkliang, Ekachai and Singh, Mithilesh and Suresh, Raksha and Akter, Fatema and Schrock, Jennifer and Renukaradhya, Gourapura J and HogenEsch, Harm},
  title = {Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {11},
  pages = {1699},
  doi = {10.3390/vaccines11111699}
}
Kostenlos starten →